My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 430

    1.

    Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.

    Lee PY, Matchar DB, Clements DA, Huber J, Hamilton JD, Peterson ED.

    Ann Intern Med. 2002 Aug 20;137(4):225-31.PMID: 12186512 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis.

    [No authors listed]

    Ann Intern Med. 2002 Aug 20;137(4):I22. No abstract available. PMID: 12186536 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

    Rothberg MB, Bellantonio S, Rose DN.

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9.PMID: 12965940 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost-effectiveness of newer treatment strategies for influenza.

    Smith KJ, Roberts MS.

    Am J Med. 2002 Sep;113(4):300-7.PMID: 12361816 [PubMed - indexed for MEDLINE]Related articles

    5.

    Management of influenza symptoms in healthy adults.

    Rothberg MB, He S, Rose DN.

    J Gen Intern Med. 2003 Oct;18(10):808-15.PMID: 14521643 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Antiviral drugs in influenza: an adjunct to vaccination in some situations.

    [No authors listed]

    Prescrire Int. 2006 Feb;15(81):21-30.PMID: 16548114 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antiviral agents for influenza: a comparison of cost-effectiveness data.

    Lynd LD, Goeree R, O'Brien BJ.

    Pharmacoeconomics. 2005;23(11):1083-106. Review.PMID: 16277546 [PubMed - indexed for MEDLINE]Related articles

    8.

    Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.

    [No authors listed]

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I27. No abstract available. PMID: 12965955 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

    Rothberg MB, Rose DN.

    Am J Med. 2005 Jan;118(1):68-77.PMID: 15639212 [PubMed - indexed for MEDLINE]Related articles

    10.

    Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

    Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K.

    Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170. Review.PMID: 14609480 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    What is the best antiviral agent for influenza infection?

    Fagan HB, Moeller AH.

    Am Fam Physician. 2004 Oct 1;70(7):1331-2. Review. No abstract available. PMID: 15508545 [PubMed - indexed for MEDLINE]Related articles

    12.

    Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.

    Schwarzinger M, Housset B, Carrat F.

    Pharmacoeconomics. 2003;21(3):215-24.PMID: 12558471 [PubMed - indexed for MEDLINE]Related articles

    13.

    Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom.

    Sander B, Gyldmark M, Hayden FG, Morris J, Mueller E, Bergemann R.

    Eur J Health Econ. 2005 Sep;6(3):244-52.PMID: 15875227 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention and early treatment of influenza in healthy adults.

    Demicheli V, Jefferson T, Rivetti D, Deeks J.

    Vaccine. 2000 Jan 6;18(11-12):957-1030. Review.PMID: 10590322 [PubMed - indexed for MEDLINE]Related articles

    15.

    Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada.

    O'Brien BJ, Goeree R, Blackhouse G, Smieja M, Loeb M.

    Value Health. 2003 Mar-Apr;6(2):116-25.PMID: 12641862 [PubMed - indexed for MEDLINE]Related articles

    16.

    [New flu therapy. Progress or burden for the budget?]

    Vogel GE.

    MMW Fortschr Med. 2000 Feb 24;142(8):14. German. No abstract available. PMID: 10810861 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antiviral therapy for influenza virus infections.

    Prober CG.

    Semin Pediatr Infect Dis. 2002 Jan;13(1):31-9. Review.PMID: 12118841 [PubMed - indexed for MEDLINE]Related articles

    18.

    Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.

    Dreitlein WB, Maratos J, Brocavich J.

    Clin Ther. 2001 Mar;23(3):327-55. Review.PMID: 11318072 [PubMed - indexed for MEDLINE]Related articles

    19.

    Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

    Sander B, Hayden FG, Gyldmark M, Garrison LP Jr.

    Pharmacoeconomics. 2006;24(4):373-86.PMID: 16605283 [PubMed - indexed for MEDLINE]Related articles

    20.

    Neuraminidase inhibitors for treatment of influenza A and B infections.

    [No authors listed]

    MMWR Recomm Rep. 1999 Dec 17;48(RR-14):1-9. Erratum in: MMWR Morb Mortal Wkly Rep 1999 Dec 17;48(49):1139. PMID: 10632443 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity